Ayvakit (avapritinib tablets) — Cigna
Myeloid/lymphoid neoplasms with eosinophilia and PDGFRA D842V mutation
Initial criteria
- Patient age ≥ 18 years
- Eosinophilia is present
- Tumor is positive for platelet-derived growth factor receptor alpha (PDGFRA) D842V mutation
Approval duration
1 year